Advancing natural killer therapies against cancer.

Cell

Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; Innate Pharma Research Laboratories, Innate Pharma, Marseille, France; APHM, Hôpital de la Timone, Marseille-Immunopôle, Marseille, France.

Published: April 2022

Natural killer (NK)-based therapies against cancer are emerging, but the understanding of NK cell functions needs to be completed to optimize these treatments. In this issue, Pan et al. (2022) show that pro-apoptotic molecules, such as BH3-mimetics, synergize with NK cells to induce mitochondria-driven apoptosis in tumor cells, thereby enhancing the efficacy of NK cell therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2022.04.006DOI Listing

Publication Analysis

Top Keywords

natural killer
8
therapies cancer
8
advancing natural
4
killer therapies
4
cancer natural
4
killer nk-based
4
nk-based therapies
4
cancer emerging
4
emerging understanding
4
understanding cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!